Mark A. Hancock
Montreal, QC H3G0B1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Erratum: A Spike-Accum bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity.
Journal: iScience
Published: October 31, 2025
Characterization of endothelin-converting enzyme 1 as a key enzyme in the multienzyme Aβ degradation pathway.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 27, 2025
A Spike-Accum bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity.
Journal: iScience
Published: November 14, 2024
Unveiling the Molecular Mechanisms of the Type-IX Secretion System's Response Regulator: Structural and Functional Insights.
Journal: bioRxiv : the preprint server for biology
Published: May 27, 2024
Inhibition of BACE1 affected both its Aβ producing and degrading activities and increased Aβ42 and Aβ40 levels at high-level BACE1 expression.
Journal: The Journal of biological chemistry
Published: February 28, 2024
Identification and characterization of calreticulin as a novel plasminogen receptor.
Journal: The Journal of biological chemistry
Published: September 18, 2023
Assembly of the Tn7 targeting complex by a regulated stepwise process.
Journal: Molecular cell
Published: June 20, 2023
A NRF2 inhibitor selectively sensitizes KEAP1 mutant tumor cells to cisplatin and gefitinib by restoring NRF2-inhibitory function of KEAP1 mutants.
Journal: Cell reports
Published: December 07, 2022
The amyloid-β1-42-oligomer interacting peptide D-AIP possesses favorable biostability, pharmacokinetics, and brain region distribution.
Journal: The Journal of biological chemistry
Published: August 20, 2021
Last Updated: 09/26/2026